Endothelium-derived endothelin-1

Pflugers Archiv European Journal of Physiology

Volumn 459, Issue 6, 2010, Pages 951-958

  Thorin, Eric ^a   Webb, David J ^b,c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cardiovascular diseases; Inflammation; Vascular tone

Indexed keywords

5 DIMETHYLAMINO N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE; ACETYLCHOLINE; ANGIOTENSIN II; BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DARUSENTAN; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; MESSENGER RNA; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; NITRIC OXIDE; PROSTACYCLIN; PROTEIN KINASE C; TEZOSENTAN; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CARDIOVASCULAR FUNCTION; CELL ADHESION; CELL PROLIFERATION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY SPASM; CORONARY BLOOD VESSEL; EXTRACELLULAR MATRIX; HEART MUSCLE CELL; HOMEOSTASIS; HUMAN; HYPOXIA; MECHANICAL STRESS; NEUTROPHIL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SHEAR STRESS; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR ENDOTHELIUM;

EID: 77952891842     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-009-0763-y     Document Type: Review

References (88)

1. RF Furchgott JV Zawadzki 1980 The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 373 376 6253831
2. RM Palmer AG Ferrige S Moncada 1987 Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 524 526 3495737 (Pubitemid 17085822)
3. JG De Mey PM Vanhoutte 1982 Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium Circ Res 51 439 447 7127680
4. PM Vanhoutte GM Rubanyi VM Miller DS Houston 1986 Modulation of vascular smooth muscle contraction by the endothelium Annu Rev Physiol 48 307 320 2871807
5. M Yanagisawa A Inoue T Ishikawa Y Kasuya S Kimura S Kumagaye K Nakajima TX Watanabe S Sakakibara K Goto, et al. 1988 Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide Proc Natl Acad Sci USA 85 6964 6967 3045827
6. M Yanagisawa H Kurihara S Kimura Y Tomobe M Kobayashi Y Mitsui Y Yazaki K Goto T Masaki 1988 A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 411 415 2451132
7. H Arai S Hori I Aramori H Ohkubo S Nakanishi 1990 Cloning and expression of a cDNA encoding an endothelin receptor Nature 348 730 732 2175396 (Pubitemid 120015147)
8. T Sakurai M Yanagisawa Y Takuwa H Miyazaki S Kimura K Goto T Masaki 1990 Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor Nature 348 732 735 2175397
9. M Clozel V Breu K Burri JM Cassal W Fischli GA Gray G Hirth BM Loffler M Muller W Neidhart, et al. 1993 Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist Nature 365 759 761 8413655
10. J McDonald M Batuwangala DG Lambert 2007 Role of urotensin II and its receptor in health and disease J Anesth 21 378 389 17680191
11. FD Russell AP Davenport 1999 Secretory pathways in endothelin synthesis Br J Pharmacol 126 391 398 10077230
12. F Brunner C Bras-Silva AS Cerdeira AF Leite-Moreira 2006 Cardiovascular endothelins: essential regulators of cardiovascular homeostasis Pharmacol Ther 111 508 531 16457892
13. G Callera R Tostes C Savoia MN Muscara RM Touyz 2007 Vasoactive peptides in cardiovascular (patho)physiology Expert Rev Cardiovasc Ther 5 531 552 17489676
14. TD Nguyen P Vequaud E Thorin 1999 Effects of endothelin receptor antagonists and nitric oxide on myogenic tone and alpha-adrenergic-dependent contractions of rabbit resistance arteries Cardiovasc Res 43 755 761 10690347
15. GM Rubanyi MA Polokoff 1994 Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology Pharmacol Rev 46 325 415 7831383
16. C Boulanger TF Luscher 1990 Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide J Clin Invest 85 587 590 2153712
17. TF Luscher Z Yang M Tschudi L von Segesser P Stulz C Boulanger R Siebenmann M Turina FR Buhler 1990 Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins Circ Res 66 1088 1094 2180587
18. P Gilbert J Tremblay E Thorin 2001 Endothelium-derived endothelin-1 reduces cerebral artery sensitivity to nitric oxide by a protein kinase C-independent pathway Stroke 32 2351 2355 11588325
19. Z Ming R Parent E Thorin M Lavallee 1998 Endothelin-dependent tone limits acetylcholine-induced dilation of resistance coronary vessels after blockade of NO formation in conscious dogs Hypertension 32 844 848 9822442
20. E Thorin 2001 Influence of nitric oxide synthase inhibition and endothelin-1 receptor blockade on acetylcholine-induced coronary artery contraction in vitro in dilated and ischemic cardiomyopathies J Cardiovasc Pharmacol 38 90 98 11444506
21. E Thorin R Parent Z Ming M Lavallee 1999 Contribution of endogenous endothelin to large epicardial coronary artery tone in dogs and humans Am J Physiol 277 H524 H532 10444477
22. P Gilbert E Thorin 2003 Endothelin-1 limits vascular smooth muscle beta-adrenergic receptor sensitivity by a PKC-dependent pathway J Cardiovasc Pharmacol 42 534 538 14508240
23. M Okajima R Parent E Thorin M Lavallee 2004 Pathophysiological plasma ET-1 levels antagonize beta-adrenergic dilation of coronary resistance vessels in conscious dogs Am J Physiol Heart Circ Physiol 287 H1476 H1483 15205173
24. RM Kedzierski M Yanagisawa 2001 Endothelin system: the double-edged sword in health and disease Annu Rev Pharmacol Toxicol 41 851 876 11264479
25. DW Anggrahini N Emoto K Nakayama B Widyantoro S Adiarto N Iwasa H Nonaka Y Rikitake YY Kisanuki M Yanagisawa K Hirata 2009 Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation Cardiovasc Res 82 143 151 19164391
26. MR Dashwood D Mehta MB Izzat M Timm AJ Bryan GD Angelini JY Jeremy 1998 Distribution of endothelin-1 (ET) receptors (ET(A) and ET(B)) and immunoreactive ET-1 in porcine saphenous vein-carotid artery interposition grafts Atherosclerosis 137 233 242 9622266
27. AP Davenport JJ Maguire 2001 The endothelin system in human saphenous vein graft disease Curr Opin Pharmacol 1 176 182 11714093
28. C Ihling T Szombathy B Bohrmann M Brockhaus HE Schaefer BM Loeffler 2001 Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis Circulation 104 864 869 11514370
29. ME Ivey N Osman PJ Little 2008 Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis Atherosclerosis 199 237 247 18436225
30. F Ruschitzka U Moehrlen T Quaschning M Lachat G Noll S Shaw Z Yang D Teupser T Subkowski MI Turina TF Luscher 2000 Tissue endothelin-converting enzyme activity correlates with cardiovascular risk factors in coronary artery disease Circulation 102 1086 1092 10973835
31. N Farhat CC Matouk AM Mamarbachi PA Marsden BG Allen E Thorin 2008 Activation of ETB receptors regulates the abundance of ET-1 mRNA in vascular endothelial cells Br J Pharmacol 153 1420 1431 18278064
32. H Yanagisawa RE Hammer JA Richardson N Emoto SC Williams S Takeda DE Clouthier M Yanagisawa 2000 Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development J Clin Invest 105 1373 1382 10811845
33. N Dhaun DM Pollock J Goddard DJ Webb 2007 Selective and mixed endothelin receptor antagonism in cardiovascular disease Trends Pharmacol Sci 28 573 579 17950470
34. NS Kirkby PW Hadoke AJ Bagnall DJ Webb 2008 The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house? Br J Pharmacol 153 1105 1119 17965745
35. FE Strachan JC Spratt IB Wilkinson NR Johnston GA Gray DJ Webb 1999 Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men Hypertension 33 581 585 9931169
36. NJ Davie RT Schermuly N Weissmann F Grimminger HA Ghofrani 2009 The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies Eur J Clin Invest 39 Suppl 2 38 49 19335746
37. SS Pullamsetti RT Schermuly 2009 Endothelin receptor antagonists in preclinical models of pulmonary hypertension Eur J Clin Invest 39 Suppl 2 3 13 19335741
38. Y Liu DD Gutterman 2009 Vascular control in humans: focus on the coronary microcirculation Basic Res Cardiol 104 211 227 19190954
39. E Thorin N Thorin-Trescases 2009 Vascular endothelial ageing, heartbeat after heartbeat Cardiovasc Res 84 24 32 19586943
40. G Heusch 2008 Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents Br J Pharmacol 153 1589 1601 18223669
41. MB Dancu JM Tarbell 2007 Coronary endothelium expresses a pathologic gene pattern compared to aortic endothelium: correlation of asynchronous hemodynamics and pathology in vivo Atherosclerosis 192 9 14 16806232
42. P D'Orleans-Juste J Labonte G Bkaily S Choufani M Plante JC Honore 2002 Function of the endothelin(B) receptor in cardiovascular physiology and pathophysiology Pharmacol Ther 95 221 238 12243796
43. M Lavallee E Thorin 2003 Role of ET-1 in the regulation of coronary circulation Can J Physiol Pharmacol 81 570 577 12839268
44. CR Bacon AP Davenport 1996 Endothelin receptors in human coronary artery and aorta Br J Pharmacol 117 986 992 8851522
45. ZS Kyriakides DT Kremastinos E Bofilis D Tousoulis A Antoniadis DJ Webb 2000 Endogenous endothelin maintains coronary artery tone by endothelin type A receptor stimulation in patients undergoing coronary arteriography Heart 84 176 182 10908255
46. S Kinlay D Behrendt M Wainstein J Beltrame JC Fang MA Creager AP Selwyn P Ganz 2001 Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries Circulation 104 1114 1118 11535565
47. PA MacCarthy NC Pegge BD Prendergast AM Shah PH Groves 2001 The physiological role of endogenous endothelin in the regulation of human coronary vasomotor tone J Am Coll Cardiol 37 137 143 11153728
48. AL Garcia-Villalon YM Amezquita L Monge N Fernandez A Salcedo G Dieguez 2008 Endothelin-1 potentiation of coronary artery contraction after ischemia-reperfusion Vascul Pharmacol 48 109 114 18262852
49. E Thorin TD Nguyen A Bouthillier 1998 Control of vascular tone by endogenous endothelin-1 in human pial arteries Stroke 29 175 180 9445348
50. S Sauvageau E Thorin L Villeneuve J Dupuis 2009 Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: role of ETB-receptor expression levels Pulm Pharmacol Ther 22 311 317 19489130
51. Gagliardini E, Corna D, Zoja C, Sangalli F, Carrara F, Rossi M, Conti S, Rottoli D, Longaretti L, Remuzzi A, Remuzzi G, Benigni A (2009) Unlike each drug alone, Lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes. Am J Physiol Renal Physiol
52. L Longaretti A Benigni 2009 Endothelin receptor selectivity in chronic renal failure Eur J Clin Invest 39 Suppl 2 32 37 19335745
53. E Thorin P Cernacek J Dupuis 1998 Endothelin-1 regulates tone of isolated small arteries in the rat: effect of hyperendothelinemia Hypertension 31 1035 1041 9535432
54. A Lerman FL Hildebrand Jr LL Aarhus JC Burnett Jr 1991 Endothelin has biological actions at pathophysiological concentrations Circulation 83 1808 1814 2022031
55. M Gossl A Mitchell A Lerman A Opazo Saez RF Schafers R Erbel T Philipp RR Wenzel 2004 Endothelin-B-receptor-selective antagonist inhibits endothelin-1 induced potentiation on the vasoconstriction to noradrenaline and angiotensin II J Hypertens 22 1909 1916 15361762
56. D Abraham M Dashwood 2008 Endothelin-role in vascular disease Rheumatology (Oxford) 47 Suppl 5 v23 v24
57. AJ Sutherland MI Nataatmadja PJ Walker L Cuttle RB Garlick MJ West 2006 Vascular remodeling in the internal mammary artery graft and association with in situ endothelin-1 and receptor expression Circulation 113 1180 1188 16505174
58. MS Goligorsky AS Budzikowski H Tsukahara E Noiri 1999 Co-operation between endothelin and nitric oxide in promoting endothelial cell migration and angiogenesis Clin Exp Pharmacol Physiol 26 269 271 10081626
59. L Morbidelli C Orlando CA Maggi F Ledda M Ziche 1995 Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors Am J Physiol 269 H686 H695 7653633
60. AG Recchia E Filice D Pellegrino A Dobrina MC Cerra M Maggiolini 2009 Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes J Mol Cell Cardiol 46 352 359 19111553
61. F Bohm J Jensen B Svane M Settergren J Pernow 2008 Intracoronary endothelin receptor blockade improves endothelial function in patients with coronary artery disease Can J Physiol Pharmacol 86 745 751 19011669
62. H Celebi AB Catakoglu H Kurtoglu M Sener R Hanavdelogullari C Demiroglu V Aytekin S Aytekin 2008 The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries Cardiovasc Revasc Med 9 144 148 18606377
63. JP Halcox KR Nour G Zalos AA Quyyumi 2001 Coronary vasodilation and improvement in endothelial dysfunction with endothelin ET(A) receptor blockade Circ Res 89 969 976 11717152
64. A Lerman BS Edwards JW Hallett DM Heublein SM Sandberg JC Burnett Jr 1991 Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis N Engl J Med 325 997 1001 1886637
65. D Alonso MW Radomski 2003 The nitric oxide-endothelin-1 connection Heart Fail Rev 8 107 115 12652164
66. AD Angerio 2005 The role of endothelin in heart failure Crit Care Nurs Q 28 355 359 16239825
67. M Barton M Yanagisawa 2008 Endothelin: 20 years from discovery to therapy Can J Physiol Pharmacol 86 485 498 18758495
68. NF Kelland DJ Webb 2006 Clinical trials of endothelin antagonists in heart failure: a question of dose? Exp Biol Med (Maywood) 231 696 699
69. S Saitoh K Matsumoto M Kamioka H Ohkawara T Kaneshiro T Ishibashi Y Maruyama 2009 Novel pathway of endothelin-1 and reactive oxygen species in coronary vasospasm with endothelial dysfunction Coron Artery Dis 20 400 408 19623039
70. E Thorin M Lucas P Cernacek J Dupuis 2000 Role of ET(A) receptors in the regulation of vascular reactivity in rats with congestive heart failure Am J Physiol Heart Circ Physiol 279 H844 H851 10924085
71. IA Vermeltfoort PG Raijmakers PW Kamphuisen 2009 Improved myocardial perfusion preceding clinical response on bosentan treatment for coronary vasospasm Acta Cardiol 64 415 417 19593957
72. C Adlbrecht D Bonderman C Plass J Jakowitsch G Beran W Sperker P Siostrzonek D Glogar G Maurer IM Lang 2007 Active endothelin is an important vasoconstrictor in acute coronary thrombi Thromb Haemost 97 642 649 17393028
73. MV Badiwala D Ramzy LC Tumiati ED Tepperman R Sheshgiri JL Prodger CM Feindel V Rao 2009 Donor pretreatment with hypertonic saline attenuates primary allograft dysfunction: a pilot study in a porcine model Circulation 120 S206 S214 19752369
74. MC Kowala PM Rose PD Stein N Goller R Recce S Beyer M Valentine D Barton SK Durham 1995 Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol Am J Pathol 146 819 826 7717449
75. M Barton CC Haudenschild LV d'Uscio S Shaw K Munter TF Luscher 1998 Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice Proc Natl Acad Sci USA 95 14367 14372 9826706
76. PJ Best CJ McKenna D Hasdai DR Holmes Jr A Lerman 1999 Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia Circulation 99 1747 1752 10190886 (Pubitemid 29162489)
77. J Bauersachs D Fraccarollo P Galuppo J Widder G Ertl 2000 Endothelin-receptor blockade improves endothelial vasomotor dysfunction in heart failure Cardiovasc Res 47 142 149 10869540
78. B Climent N Fernandez E Sanz A Sanchez L Monge AL Garcia-Villalon G Dieguez 2005 Enhanced response of pig coronary arteries to endothelin-1 after ischemia-reperfusion. Role of endothelin receptors, nitric oxide and prostanoids Eur J Pharmacol 524 102 110 16243311
79. D Hasdai V Mathew RS Schwartz LA Smith DR Holmes Jr ZS Katusic A Lerman 1997 Enhanced endothelin-B-receptor-mediated vasoconstriction of small porcine coronary arteries in diet-induced hypercholesterolemia Arterioscler Thromb Vasc Biol 17 2737 2743 9409250
80. PH Dagassan V Breu M Clozel A Kunzli P Vogt M Turina W Kiowski JP Clozel 1996 Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries J Cardiovasc Pharmacol 27 147 153 8656649
81. J Fan H Unoki S Iwasa T Watanabe 2000 Role of endothelin-1 in atherosclerosis Ann NY Acad Sci 902 84 93 10865828 discussion 93-84
82. MR Dashwood M Timm JR Muddle AC Ong JR Tippins R Parker D McManus AJ Murday BP Madden JC Kaski 1998 Regional variations in endothelin-1 and its receptor subtypes in human coronary vasculature: pathophysiological implications in coronary disease Endothelium 6 61 70 9832333
83. MR Dashwood JC Tsui 2002 Endothelin-1 and atherosclerosis: potential complications associated with endothelin-receptor blockade Atherosclerosis 160 297 304 11849651
84. N Dhaun CJ Ferro AP Davenport WG Haynes J Goddard DJ Webb 2007 Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease Nephrol Dial Transplant 22 3228 3234 17556408
85. N Dhaun IM Macintyre V Melville P Lilitkarntakul NR Johnston J Goddard DJ Webb 2009 Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease Hypertension 54 113 119 19506099
86. F Bohm E Beltran J Pernow 2005 Endothelin receptor blockade improves endothelial function in atherosclerotic patients on angiotensin converting enzyme inhibition J Intern Med 257 263 271 15715683
87. Weber MA, Black H, Bakris G, Krum H, Linas S, Weiss R, Linseman JV, Wiens BL, Warren MS, Lindholm LH (2009) A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial. Lancet
88. N Dhaun J Goddard DE Kohan DM Pollock EL Schiffrin DJ Webb 2008 Role of endothelin-1 in clinical hypertension: 20 years on Hypertension 52 452 459 18678788